Bristol Myers Squibb· @bmsnews · X·· 2026-06-02AI 评分22
AI 导读
新数据将在 #ASCO26 上公布，涉及一款 EGFRxHER3 双特异性抗体偶联药物用于三阴性乳腺癌和转移性食管鳞状细胞癌。阅读更多：https://bit.ly/43ME29S
正文
#MEDIA: New data will be presented at #ASCO26 for an EGFRxHER3 bispecific antibody-drug conjugate in triple negative breast cancer and in metastatic esophageal squamous cell carcinoma. Read more: https://bit.ly/43ME29S
来源：Bristol Myers Squibb · x.com